Jove
Visualize
お問い合わせ

関連する概念動画

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

28
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
28
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

50
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
50
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

37
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
37
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー
  1. ホーム
  2. Crt患者におけるqrs収縮と相関するシンクアトリオベントリキュラー対名目最適化の臨床およびエコーカルディオグラフィのアウトカム
  1. ホーム
  2. Crt患者におけるqrs収縮と相関するシンクアトリオベントリキュラー対名目最適化の臨床およびエコーカルディオグラフィのアウトカム

関連する実験動画

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.6K

CRT患者におけるQRS収縮と相関するシンクアトリオベントリキュラー対名目最適化の臨床およびエコーカルディオグラフィのアウトカム

Gamela Nasr1, Aliaa Tarek Mahfouz2,3, Mostafa Wanees Ahmed El Husseny4,5

  • 1Department of Cardiology, Faculty of medicine, Suez Canal university, Ismailia, Egypt.

BMC cardiovascular disorders
|August 28, 2025

PubMed で要約を見る

まとめ
この要約は機械生成です。

新規のSyncAVアルゴリズムは,心臓再同期療法 (CRT) を受けている患者のQRS期間を著しく短縮し,臨床およびエコーカルディオグラフィのアウトカムを改善しました. このデバイスベースのアプローチは 心不全の管理を最適化します

キーワード:
バイブントリキュラーペース心臓再同期療法心筋病心不全機械的な改造QRSの持続時間

さらに関連する動画

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

903
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

3.8K

関連する実験動画

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.6K
Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

903
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

3.8K

科学分野:

  • 心臓病科
  • 生物医学工学
  • 医療機器

背景:

  • 心臓再同期療法 (CRT) は,心不全 (HF) の治療に不可欠です.
  • CRTにおける心房静脈 (AV) 遅延の最適化により,患者の反応が改善されます.
  • 新しいアルゴリズムは,自動タイミングの最適化を介してCRTの有効性を高めることを目的としています.

研究 の 目的:

  • バイブントリキュラー (BiV) ペースを最適化するためのSyncAVアルゴリズムの有効性を評価する.
  • 標準値と比較して,SyncAVが心臓のシンクロニーと急性血液動力学的反応を改善するかどうかを評価する.
  • CRT患者におけるQRSの持続時間と臨床結果に対するSyncAVの影響を調査する.

主な方法:

  • CRT移植を施された左ブランクブロックの患者36人を研究した.
  • 2つのペースモードを比較した. 名目AV遅延とSyncAVアルゴリズム.
  • 植入後1ヶ月と6ヶ月で心電図と心音図を採取した.

主要な成果:

  • SyncAVは,名目設定と比較してQRSの持続時間を大幅に短縮しました (P < 0. 001).
  • SyncAVで臨床およびエコーカルディオグラフィのパラメータが改善された.
  • SyncAVアルゴリズムを使用した患者では,QRSの延長はなかった.
  • 結論:

    • SyncAV アルゴリズムを用いた患者専用のBiVペースは,移植後の電気的最適化を容易にする.
    • 自動デバイスベースのアルゴリズムは 内側の心房回路のタイミングに効果的に調整されます.
    • SyncAVは,選択されたLBBB患者のCRT結果を改善するための有望なアプローチを提供します.